PATENT CLAIM ANALYSIS

Application Number: 15978670
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["514", "04400A"]

Abstract:
The invention relates to a saRNAs useful in upregulating the expression of a target gene and therapeutic compositions comprising the saRNA. Methods of using the saRNA and the therapeutic compositions are also provided.

Claim (Index 9):
The saRNA of  claim 8 , wherein the antisense strand of the saRNA duplex is at least 80% identical to the reverse complement of a nucleotide sequence selected from the group consisting of SEQ ID NOs: 72-90, 167-184, 257-308, 517-525, 562-576, 637-642, 667-688, 777-802, 907-913, 942-964, 1057-1061, 1090-1100, 1145-1149, 1170-1185, 1250-1268, 1345-1359, 1425-1435, 1480-1500, 1605-1611, 1640-1647, 1680-1690, 1735-1751, 1820-1833, 1890-1898, 1935-1951, and 2020-2060.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 93.0
- Lexical Diversity: 1.4
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13877968', '13096817', '15038332', '11910722', '14504303']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7658890444114194
- 35 USC 102 Novelty (BERT): 0.5038482649742871
- Combined Prediction Score: 0.7396849664677061
- Mean Citation Score: 239.24641000000005
- Max Citation Score: 247.44456
- Similarity Product: 183.64933019775867

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test